Thus, targeting STEAP1 and SP-NK1R signaling pathways, along with addressing ferroptosis, may provide therapeutic benefits in mitigating sepsis-induced ALI by reducing ferroptosis and associated inflammation. The gene discussed is STEAP1; the disease is acute respiratory distress syndrome.